Polymeric Excipients in the Technology of Floating Drug Delivery Systems

Overview

Journal Pharmaceutics

Publisher MDPI

Date 2022 Dec 23

PMID 36559272

Authors

Evgenia V Blynskaya

Sergey V Tishkov

Vladimir P Vinogradov

Konstantin V Alekseev

Anna I Marakhova

Alexandre A Vetcher

Affiliations

Soon will be listed here.

Abstract

The combination of targeted transport and improvement of the release profile of the active pharmaceutical ingredient (API) is a current trend in the development of oral medicinal products (MP). A well-known way to implement this concept is to obtain floating gastroretentive delivery systems that provide a long stay of the dosage form (DF) on the surface of the stomach contents. The nomenclature of excipients (Es) of a polymeric nature used in the technology of obtaining floating drug delivery systems (FDDS) is discussed. Based on the data presented in research papers, the most widely used groups of polymers, their properties, and their purpose in various technological approaches to achieving buoyancy have been determined. In addition, ways to modify the release of APIs in these systems and the Es used for this are described. The current trends in the use of polymers in the technology of floating dosage forms (FDF) and generalized conclusions about the prospects of this direction are outlined.

Citing Articles

Algae-Based Nanoparticles for Oral Drug Delivery Systems.

Drori E, Patel D, Coopersmith S, Rahamim V, Drori C, Jadhav S Mar Drugs. 2024; 22(3).

PMID: 38535439 PMC: 10971847. DOI: 10.3390/md22030098.

Optimization and In Vitro Characterization of Telmisartan Loaded Sodium Alginate Beads and Its In Vivo Efficacy Investigation in Hypertensive Induced Animal Model.

Uthumansha U, Prabahar K, Gajapathy D, El-Sherbiny M, Elsherbiny N, Qushawy M Pharmaceutics. 2023; 15(2).

PMID: 36840031 PMC: 9959044. DOI: 10.3390/pharmaceutics15020709.

References

Eberle V, Schoelkopf J, Gane P, Alles R, Huwyler J, Puchkov M . Floating gastroretentive drug delivery systems: Comparison of experimental and simulated dissolution profiles and floatation behavior. Eur J Pharm Sci. 2014; 58:34-43. DOI: 10.1016/j.ejps.2014.03.001. View

Vrettos N, Roberts C, Zhu Z . Gastroretentive Technologies in Tandem with Controlled-Release Strategies: A Potent Answer to Oral Drug Bioavailability and Patient Compliance Implications. Pharmaceutics. 2021; 13(10). PMC: 8539558. DOI: 10.3390/pharmaceutics13101591. View

Kukati L, Chittimalli K, Shaik N, Thoudoju S . Formulation and Evaluation of Sintered Floating Tablets of Cefpodoxime Proxetil. Turk J Pharm Sci. 2020; 15(3):278-290. PMC: 7227827. DOI: 10.4274/tjps.59454. View

Khan M, Akhtar N, Sharma V, Pathak K . Product development studies on sonocrystallized curcumin for the treatment of gastric cancer. Pharmaceutics. 2015; 7(2):43-63. PMC: 4491650. DOI: 10.3390/pharmaceutics7020043. View

Thombre N, Gide P . Floating-bioadhesive gastroretentive Caesalpinia pulcherrima-based beads of amoxicillin trihydrate for Helicobacter pylori eradication. Drug Deliv. 2014; 23(2):405-19. DOI: 10.3109/10717544.2014.916766. View

Adel S, ElKasabgy N . Design of innovated lipid-based floating beads loaded with an antispasmodic drug: in-vitro and in-vivo evaluation. J Liposome Res. 2013; 24(2):136-49. DOI: 10.3109/08982104.2013.857355. View

Rajab M, Jouma M, Neubert R, Dittgen M . Influence of water-soluble polymers on the in vitro performance of floating mucoadhesive tablets containing metformin. Drug Dev Ind Pharm. 2013; 40(7):879-85. DOI: 10.3109/03639045.2013.789052. View

Pi C, Feng T, Liang J, Liu H, Huang D, Zhan C . Polymer blends used to develop felodipine-loaded hollow microspheres for improved oral bioavailability. Int J Biol Macromol. 2018; 112:1038-1047. DOI: 10.1016/j.ijbiomac.2018.02.041. View

Haimhoffer A, Vasvari G, Trencsenyi G, Beresova M, Budai I, Czomba Z . Process Optimization for the Continuous Production of a Gastroretentive Dosage Form Based on Melt Foaming. AAPS PharmSciTech. 2021; 22(5):187. PMC: 8217006. DOI: 10.1208/s12249-021-02066-y. View

10.

Abdelbary A, Elsayed I, Hassen Elshafeey A . Design and development of novel lipid based gastroretentive delivery system: response surface analysis, in-vivo imaging and pharmacokinetic study. Drug Deliv. 2013; 22(1):37-49. DOI: 10.3109/10717544.2013.868960. View

11.

Vo A, Feng X, Morott J, Pimparade M, Tiwari R, Zhang F . A novel floating controlled release drug delivery system prepared by hot-melt extrusion. Eur J Pharm Biopharm. 2015; 98:108-21. PMC: 4691578. DOI: 10.1016/j.ejpb.2015.11.015. View

12.

Rao G, Mandapalli P, Manthri R, Reddy V . Development and in vivo evaluation of gastroretentive delivery systems for cefuroxime axetil. Saudi Pharm J. 2013; 21(1):53-9. PMC: 3745169. DOI: 10.1016/j.jsps.2012.01.003. View

13.

Razavi M, Karimian H, Yeong C, Fadaeinasab M, Khaing S, Chung L . Gastroretentive behavior of orally administered radiolabeled tamarind seed formulations in rabbits validated by gamma scintigraphy. Drug Des Devel Ther. 2016; 11:1-15. PMC: 5182038. DOI: 10.2147/DDDT.S115466. View

14.

Jagdale S, Bari N, Kuchekar B, Chabukswar A . Optimization studies on compression coated floating-pulsatile drug delivery of bisoprolol. Biomed Res Int. 2013; 2013:801769. PMC: 3842062. DOI: 10.1155/2013/801769. View

15.

Svagan A, Mullertz A, Lobmann K . Floating solid cellulose nanofibre nanofoams for sustained release of the poorly soluble model drug furosemide. J Pharm Pharmacol. 2017; 69(11):1477-1484. DOI: 10.1111/jphp.12793. View

16.

Teaima M, Abdel Hamid M, Shoman N, Jasti B, El-Nabarawi M . Promising Swellable Floating Bupropion Tablets: Formulation, in vitro/in vivo Evaluation and Comparative Pharmacokinetic Study in Human Volunteers. Drug Des Devel Ther. 2020; 14:2741-2757. PMC: 7368561. DOI: 10.2147/DDDT.S258571. View

17.

Adebisi A, Conway B . Preparation and characterisation of gastroretentive alginate beads for targeting H. pylori. J Microencapsul. 2013; 31(1):58-67. DOI: 10.3109/02652048.2013.805840. View

18.

Kesarla R, Vora P, Sridhar B, Patel G, Omri A . Formulation and evaluation of floating tablet of H2-receptor antagonist. Drug Dev Ind Pharm. 2014; 41(9):1499-511. DOI: 10.3109/03639045.2014.959969. View

19.

Chen Y, Ho H, Chiu C, Sheu M . Development and characterization of a gastroretentive dosage form composed of chitosan and hydroxyethyl cellulose for alendronate. Drug Des Devel Ther. 2014; 8:67-78. PMC: 3883582. DOI: 10.2147/DDDT.S52791. View

20.

Bhardwaj T, Kanwar M, Lal R, Gupta A . Natural gums and modified natural gums as sustained-release carriers. Drug Dev Ind Pharm. 2000; 26(10):1025-38. DOI: 10.1081/ddc-100100266. View